COPD Exacerbation
Respiratory
0
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
AstraZenecaCAMBRIDGE, United Kingdom
1 programComparative Effectiveness of Symbicort vs. Spiriva Among COPD PatientsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
Verona PharmaHIRT
Monaghan MedicalBAN
AstraZenecaComparative Effectiveness of Symbicort vs. Spiriva Among COPD Patients
Clinical Trials (3)
Total enrollment: 2,396 patients across 3 trials
High-intensity Resistance Training in Post-exacerbation COPD
Start: Oct 2025Est. completion: May 2028
N/ARecruiting
Breath-actuated Nebulizers in Acute COPD Exacerbations
Start: Oct 2019Est. completion: Jul 2021
N/AUnknown
Comparative Effectiveness of Symbicort vs. Spiriva Among COPD Patients
Start: Aug 2013Est. completion: Nov 20132,396 patients
N/ACompleted
Related Jobs in Respiratory
Regional Gene Therapy Consultant - Upper Midwest (IL/WI/MN)
Krystal Biotech
2h ago
$185K - $215K/yr
Regional Gene Therapy Consultant - Southwest (CO/AZ/NM/UT)
Krystal Biotech
2h ago
$185K - $215K/yr
Ausbildung zum Pharmakanten (m/w/d)
Ferring Pharmaceuticals
Kiel, Germany
Yesterday
Marketing Intern – Vertex Iberia (Spain)
Vertex Pharmaceuticals
Madrid, Spain
Yesterday
Sales Rep Neurology Region Leipzig, Halle, Gera, Jena, Weimar DE_G2M110105 - befristet bis 31.03.2027 (all genders)
Sanofi
Berlin
Yesterday
Laboratory Assistant (m/w/d)
Ferring Pharmaceuticals
Kiel, Germany
2d ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 2,396 patients
3 companies competing in this space